Overview of Key Findings from the 2012 Report

Fact Sheet

This is the 31st tobacco-related Surgeon General’s report issued since 1964. It describes the epidemic of tobacco use among youth ages 12 through 17 and young adults ages 18 through 25, including the epidemiology, causes, and health effects of this tobacco use and interventions proven to prevent it. Scientific evidence contained in this report supports the following facts:

We have made progress in reducing tobacco use among youth; however, far too many young people are still using tobacco. Today, more than 600,000 middle school students and 3 million high school students smoke cigarettes. Rates of decline for cigarette smoking have slowed in the last decade and rates of decline for smokeless tobacco use have stalled completely.

  • Every day, more than 1,200 people in this country die due to smoking. For each of those deaths, at least two youth or young adults become regular smokers each day. Almost 90% of those replacement smokers smoke their first cigarette by age 18.
  • There could be 3 million fewer young smokers today if success in reducing youth tobacco use that was made between 1997 and 2003 had been sustained.
  • Rates of smokeless tobacco use are no longer declining, and they appear to be increasing among some groups.
  • Cigars, especially cigarette-sized cigars, are popular with youth. One out of five high school males smokes cigars, and cigar use appears to be increasing among other groups.
  • Use of multiple tobacco products—including cigarettes, cigars, and smokeless tobacco—is common among young people.
  • Prevention efforts must focus on young adults ages 18 through 25, too. Almost no one starts smoking after age 25. Nearly 9 out of 10 smokers started smoking by age 18, and 99% started by age 26. Progression from occasional to daily smoking almost always occurs by age 26.

Tobacco use by youth and young adults causes both immediate and long-term damage. One of the most serious health effects is nicotine addiction, which prolongs tobacco use and can lead to severe health consequences. The younger youth are when they start using tobacco, the more likely they’ll be addicted.

  • Early cardiovascular damage is seen in most young smokers; those most sensitive die very young.
  • Smoking reduces lung function and retards lung growth. Teens who smoke are not only short of breath today, they may end up as adults with lungs that will never grow to full capacity. Such damage is permanent and increases the risk of chronic obstructive pulmonary disease.
  • Youth are sensitive to nicotine and can feel dependent earlier than adults. Because of nicotine addiction, about three out of four teen smokers end up smoking into adulthood, even if they intend to quit after a few years.
  • Among youth who persist in smoking, a third will die prematurely from smoking.

Youth are vulnerable to social and environmental influences to use tobacco; messages and images that make tobacco use appealing to them are everywhere.

  • Young people want to fit in with their peers. Images in tobacco marketing make tobacco use look appealing to this age group.
  • Youth and young adults see smoking in their social circles, movies they watch, video games they play, websites they visit, and many communities where they live. Smoking is often portrayed as a social norm, and young people exposed to these images are more likely to smoke.
  • Youth identify with peers they see as social leaders and may imitate their behavior; those whose friends or siblings smoke are more likely to smoke.
  • Youth who are exposed to images of smoking in movies are more likely to smoke. Those who get the most exposure to onscreen smoking are about twice as likely to begin smoking as those who get the least exposure. Images of smoking in movies have declined over the past decade; however, in 2010 nearly a third of top-grossing movies produced for children—those with ratings of G, PG, or PG-13— contained images of smoking.

Tobacco companies spend more than a million dollars an hour in this country alone to market their products. This report concludes that tobacco product advertising and promotions still entice far too many young people to start using tobacco.

  • The tobacco industry has stated that its marketing only promotes brand choices among adult smokers. Regardless of intent, this marketing encourages underage youth to smoke. Nearly 9 out of 10 smokers start smoking by age 18, and more than 80% of underage smokers choose brands from among the top three most heavily advertised.
  • The more young people are exposed to cigarette advertising and promotional activities, the more likely they are to smoke.
  • The report finds that extensive use of price-reducing promotions has led to higher rates of tobacco use among young people than would have occurred in the absence of these promotions.
  • Many tobacco products on the market appeal to youth. Some cigarette-sized cigars contain candy and fruit flavoring, such as strawberry and grape.
  • Many of the newest smokeless tobacco products do not require users to spit, and others dissolve like mints; these products include snus—a spitless, dry snuff packaged in a small teabag-like sachet—and dissolvable strips and lozenges. Young people find these products appealing in part because they can be used without detection at school or other places where smoking is banned. However, these products cause and sustain nicotine addiction, and most youth who use them also smoke cigarettes.
  • Through the use of advertising and promotional activities, packaging, and product design, the tobacco industry encourages the myth that smoking makes you thin. This message is especially appealing to young girls. It is not true—teen smokers are not thinner than nonsmokers.

Comprehensive, sustained, multi-component programs can cut youth tobacco use in half in 6 years.

  • Prevention is critical. Successful multi-component programs prevent young people from starting to use tobacco in the first place and more than pay for themselves in lives and health care dollars saved.
  • Strategies that comprise successful comprehensive tobacco control programs include mass media campaigns, higher tobacco prices, smoke-free laws and policies, evidence-based school programs, and sustained community-wide efforts.
  • Comprehensive tobacco control programs are most effective when funding for them is sustained at levels recommended by the Centers for Disease Control and Prevention.

History of the Surgeon General’s Reports on Smoking and Health

On January 11, 1964, Luther L. Terry, M.D., Surgeon General of the U.S. Public Health Service, released the first report of the Surgeon General’s Advisory Committee on Smoking and Health.

On the basis of more than 7,000 articles relating to smoking and disease already available at that time in the biomedical literature, the Advisory Committee concluded that cigarette smoking is—

  • A cause of lung cancer and laryngeal cancer in men
  • A probable cause of lung cancer in women
  • The most important cause of chronic bronchitis

The release of the report was the first in a series of steps, still being taken more than 40 years later, to diminish the impact of tobacco use on the health of the American people.

For several days, the report furnished newspaper headlines across the country and lead stories on television newscasts. Later it was ranked among the top news stories of 1964.

During the more than 40 years that have elapsed since that report, individual citizens, private organizations, public agencies, and elected officials have pursued the Advisory Committee’s call for “appropriate remedial action.”

Early on, the U.S. Congress adopted the Federal Cigarette Labeling and Advertising Act of 1965 and the Public Health Cigarette Smoking Act of 1969. These laws—

  • Required a health warning on cigarette packages
  • Banned cigarette advertising in the broadcasting media
  • Called for an annual report on the health consequences of smoking

In September 1965, the Public Health Service established a small unit called the National Clearinghouse for Smoking and Health.

Through the years, the Clearinghouse and its successor organization, the Centers for Disease Control and Prevention’s Office on Smoking and Health, have been responsible for 29 reports on the health consequences of smoking.

In close cooperation with voluntary health organizations, the Public Health Service has—

  • Supported successful state and community programs to reduce tobacco use
  • Disseminated research findings related to tobacco use
  • Ensured the continued public visibility of antismoking messages

Within this evolving social milieu, the population has given up smoking in increasing numbers. Nearly half of all living adults who ever smoked have quit.

The antismoking campaign is a major public health success with few parallels in the history of public health. It is being accomplished despite the addictive nature of tobacco and the powerful economic forces promoting its use.

However, more than 45 million American adults still smoke, more than 8 million are living with a serious illness caused by smoking, and about 438,000 Americans die prematurely each year as a result of tobacco use.

Efforts to implement proven interventions must be continued and expanded.

Tobacco Control Act

PLAW-111publ31  This is the full publication in PDF.  Below is an overview of the same.  The “Tobacco Control Act” became law on June 22, 2009.

An Overview Of The Family Smoking Prevention and Tobacco Control Act:  Consumer Fact Sheet

The Tobacco Control Act:

  • Recognizes that virtually all new users of tobacco products are under 18 – the minimum legal age to purchase these products.  Many new users will become addicted before they are old enough to understand the risks and ultimately will die too young of tobacco-related diseases. The Tobacco Control Act seeks to, among other things, prevent and reduce tobacco use by these young people.
  • Recognizes that tobacco products are legal products available for adult use, prohibits false or misleading labeling and advertising for tobacco products and provides the tobacco industry with several mechanisms to submit an application to FDA for new products or tobacco products with modified risk claims.
  • Gives FDA enforcement authority as well as a broad set of sanctions for violations of the law, and directs FDA to contract with states to assist FDA with retailer inspections.

Note: This overview highlights some of the provisions of the Tobacco Control Act and is not intended to be a comprehensive guide or to reflect FDA’s interpretation of the Tobacco Control Act.  For complete information, you must read the entire law. For your convenience, in the text below we provide the section number of the Tobacco Control Act and a link to the full text of the section.

What the Tobacco Control Act does

Restricts cigarettes and smokeless tobacco retail sales to youth by directing FDA to issue regulations which, among other things:

  • Require proof of age to purchase these tobacco products – the federal minimum age to purchase is 18 – Sec. 102
  • Require face-to-face sales, with certain exemptions for vending machines and self-service displays in adult-only facilities – Sec. 102
  • Ban the sale of packages of fewer than 20 cigarettes – Sec. 102
  • Allow certain exemptions in adult-only facilities – Sec. 102

Restricts tobacco product advertising and marketing to youth by directing FDA to issue regulations which, among other things:  

  • Limit color and design of packaging and advertisements, including audio-visual advertisements – Sec. 102 (However, implementation of this provision is uncertain due to pending litigation. See Discount Tobacco City & Lottery v. USA, formerly Commonwealth Brands v. FDA)
  • Ban tobacco product sponsorship of sporting or entertainment events under the brand name of cigarettes or smokeless tobacco – Sec.102
  • Ban free samples of cigarettes and brand-name non-tobacco promotional items – Sec. 102

Note: Among its many provisions, the Tobacco Control Act required FDA to reissue its 1996 final regulations aimed at restricting the sale and distribution of cigarette and smokeless tobacco products. (Section 102)

The Tobacco Control Act specifically:

  • Prohibits “reduced harm” claims including “light,” “low,” or “mild,” without an FDA order to allow marketing – Sec. 911 of the Federal Food, Drug, and Cosmetic Act (FDCA)
  • Requires industry to submit marketing research documents – Sec. 904 of the FDCA

Requires bigger, more prominent warning labels for cigarettes and smokeless tobacco products. However, the implementation date is uncertain, due to ongoing proceedings in the case of R. J. Reynolds Tobacco Co. v. U.S. Food and Drug Administration, No, 11-1482 (D.D.C.), on appeal, No 11-5332 (D.C.Cir.).

  • Packaging and advertisements for cigarettes and smokeless tobacco must have revised warning labels with a larger font size. Font colors are limited to white on a black background or black on a white background. – Sec. 201 and 204
  • Cigarette package health warnings will be required to cover the top 50 percent of both the front and rear panels of the package, and the nine specific warning messages must be equally and randomly displayed and distributed in all areas of the United States. These messages must be accompanied by color graphics showing the negative health consequences of smoking cigarettes. – Sec. 201
  • Smokeless tobacco package warnings must cover 30 percent of the two principal display panels, and the four specific required messages must be equally and randomly displayed and distributed in all areas of the United States. – Sec. 204

Gives FDA authority over, among other things:

  • Registration and inspection of tobacco companies – Sec. 905 of the FDCA
    • Requires owners and operators of tobacco companies to register annually and be subject to inspection every 2 years by FDA.
  • Standards for tobacco products – Sec. 907 of the FDCA
    • Allows FDA to require standards for tobacco products (for example, tar and nicotine levels) as appropriate to protect public health.
    • Bans cigarettes with characterizing flavors (except menthol and tobacco).
  • “Premarket Review” of new tobacco products – Sec 910 and 905 of the FDCA
    • Requires manufacturers who wish to market a new tobacco product to obtain a marketing order from FDA prior to marketing that new product.
  • “Modified risk” products – Sec. 911 of the FDCA
    • Requires manufacturers who wish to market a tobacco product with a claim of reduced harm to obtain a marketing order from FDA.
  • Enforcement action plan for advertising and promotion restrictions – Sec 105
    • FDA published a document entitled “Enforcement Action Plan for Promotion and Advertising Restrictions.”
    • The action plan details FDA’s current thinking on how it intends to enforce certain requirements under the Tobacco Control Act.

The Tobacco Control Act also requires

  • Tobacco industry must disclose research on the health, toxicological, behavioral, or physiologic effects of tobacco use. – Sec 904 of the FDCA
  • Tobacco industry must disclose information on ingredients and constituents in tobacco products; and must notify FDA of any changes. – Sec 904 of the FDCA

How FDA oversees the implementation of the Tobacco Control Act

 Among other things, FDA:
  • Established the Center for Tobacco Products to implement the Tobacco Control Act – Sec. 901 of the FDCA
  • Established the Tobacco Products Scientific Advisory Committee to provide advice, information, and recommendations to the FDA – Sec. 917 of the FDCA
  • Assesses user fees on tobacco product manufacturers and importers based on their market share. The fees are used to fund FDA activities related to the regulation of tobacco products – Sec. 919 of the FDCA
  • Reports to Congress on how best to encourage companies to develop innovative products that help people stop smoking.
  • Issues regulations and conducts inspections to investigate illicit trade in tobacco products – Sec. 920 of the FDCA
  • Convenes a panel of experts to study the public health implications of raising the minimum age to purchase tobacco products – Sec. 104

Limits on FDA’s authority

FDA cannot:
  • Ban certain specified classes of tobacco products – Sec. 907 of the FDCA
  • Require the reduction of nicotine yields to zero – Sec. 907 of the FDCA
  • Require prescriptions to purchase tobacco products – Sec. 906 of the FDCA
  • Ban face-to-face tobacco sales in any particular category of retail outlet – Sec. 906 of the FDCA

The Tobacco Control Act preserves the authority of state, local, and tribal governments to regulate tobacco products in certain specific respects. It also prohibits, with certain exceptions, state and local requirements that are different from, or in addition to, requirements under the provisions of the FDCA relating to specified areas.